Skip to content

A plain-English review of vitamin D and skin cancer. There is real biological plausibility that it could help, and low vitamin D at melanoma diagnosis is linked to worse tumours — but the trials have been disappointing: supplements have not been shown to prevent skin cancer or improve melanoma survival. The sensible approach is to correct deficiency, not chase high levels.

Prevention

Vitamin D and skin cancer — what the evidence actually shows

A plain-English review of vitamin D and skin cancer. There is real biological plausibility that it could help, and low vitamin D at melanoma diagnosis is linked to worse tumours — but the trials have been disappointing: supplements have not been shown to prevent skin cancer or improve melanoma survival. The sensible approach is to correct deficiency, not chase high levels.

Portrait of Dr Christopher Irwin

By Dr Christopher Irwin, MBChB, FRACGP, MMed (Skin Cancer), FACAM, MSCCA

Last reviewed 2026-06-06 · 11 min read · Editorial policy

Quick summary

Vitamin D is a common and reasonable question for anyone thinking about skin cancer — especially patients who protect their skin carefully. The honest picture is nuanced: low vitamin D at the time of a melanoma diagnosis is linked to worse tumours, and there is real biological reason to think vitamin D could help. But when researchers have actually tested taking vitamin D tablets in high-quality randomised trials, the results have been disappointing — no proven reduction in skin cancer, and no improvement in melanoma survival. The most sensible approach is to correct a genuine deficiency, not chase a high level, and to get vitamin D from diet and supplements rather than the sun.

Patients often ask whether keeping their vitamin D high could prevent skin cancer, or help if they have already had one. It is a fair question, and the science behind it is genuinely interesting — but it is also one of the easiest areas in medicine to misread. This page explains, in plain terms, what we actually know.

The short answer

  • Correcting a deficiency is worthwhile for your general health, and may be recommended around a melanoma diagnosis. (14)
  • Deliberately pushing vitamin D high with tablets is not a proven way to prevent skin cancer or improve melanoma outcomes. (2,7)
  • Never use the sun as your vitamin D source if you are concerned about skin cancer. (15)

Why this question is so easy to get wrong

The whole topic is tangled by one simple fact: sunlight does two opposite things at once. It makes your skin produce vitamin D, and it damages skin and causes skin cancer.

So if a study finds that people with higher vitamin D levels get more skin cancer, that usually does not mean vitamin D is harmful — it means those people simply spent more time in the sun. Their high vitamin D is a marker of UV exposure, not the cause of their cancer. The same trap works in reverse for prognosis: people with higher vitamin D are often leaner, fitter and healthier overall, which can make vitamin D look protective when it is really just tracking general good health. (10,11)

This is why a vitamin D blood level and the effect of a vitamin D tablet are not the same thing — and why the most reliable answers come from randomised trials, where people are randomly given vitamin D or a dummy tablet.

Why we would hope vitamin D helps (the biology)

There is real, legitimate science behind the idea. Vitamin D works through a docking point on cells called the vitamin D receptor (VDR), and in laboratory and animal studies switching this pathway on appears to:

  • slow down cell multiplication and encourage cells to mature normally rather than grow out of control
  • support repair of UV-damaged DNA and reduce inflammation
  • quieten growth signals (such as the Wnt/β-catenin pathway) that can drive cancer

Mice bred to lack the vitamin D receptor develop more UV-induced skin tumours, and newer work even links vitamin D to immune activity against tumours via the gut microbiome. (8) In other words, the plausibility is strong. The catch is that strong laboratory plausibility does not always translate into benefit in real people — and here, it largely has not.

Does taking vitamin D prevent skin cancer? (the trials)

This is where the hope meets the data. The large randomised trials are negative:

  • Women’s Health Initiative — calcium plus low-dose vitamin D did not reduce melanoma or non-melanoma skin cancer overall. (1)
  • VITAL — a ~25,000-person trial of vitamin D 2000 IU/day found no reduction in total invasive cancer. (2) A later analysis suggested fewer advanced cancers in aggregate, but that was across all cancers, not skin specifically. (3)
  • D-Health (Australia) — monthly vitamin D in over 21,000 older adults did not reduce keratinocyte (basal and squamous cell) cancers, with a hint of more skin excisions in those aged 70+. (4)
  • FIND (Finland) — vitamin D 1600 or 3200 IU/day for five years did not reduce cancer. (5)

Across the board, when vitamin D is tested properly for prevention, skin cancer rates do not fall. (11)

Does vitamin D help after a melanoma diagnosis?

The most important study here is the randomised, double-blind, placebo-controlled ViDMe trial. It gave melanoma patients high-dose vitamin D after surgery, successfully raised their vitamin D levels — and still found no improvement in relapse-free survival, melanoma-specific death, or overall survival. (7) An earlier stage II melanoma trial was too small to give a clear answer. (6)

One 2023 study in advanced melanoma reported that patients on immunotherapy did better if they had normal vitamin D, (8) but that study did not randomise supplementation, so it is vulnerable to the confounding described above and is best treated as a clue for future research — not a reason to act. A separate analysis of high-risk melanoma patients found vitamin D levels did not predict outcome. (9)

But low vitamin D does flag worse disease

Here is the part that is genuinely real and clinically useful: in several studies, melanoma patients with low vitamin D at diagnosis tend to have thicker tumours and, in some cohorts, worse survival. (10,12) A meta-analysis found lower vitamin D associated with greater tumour thickness and higher mortality, (12) and another found that while vitamin D was not clearly tied to getting melanoma, lower levels were linked to thicker melanomas. (13)

This is why measuring vitamin D around a diagnosis makes sense. But “low vitamin D signals worse disease” is not the same as “taking vitamin D will make the disease better” — and, as the trials above show, the second part has not held up.

What the guidelines say

  • NICE (UK) recommends measuring vitamin D at melanoma diagnosis and correcting low levels — while explicitly calling for more trials, because the survival question is unresolved. (14)
  • Cancer Council Australia and other public-health bodies advise getting vitamin D from diet and supplements, not deliberate sun exposure — there is no level of UV that maximises vitamin D without raising skin cancer risk. (15)
  • NIH Office of Dietary Supplements: a blood level of ≥50 nmol/L (20 ng/mL) is sufficient for most people, while >125 nmol/L (50 ng/mL) can cause harm, and the usual adult upper limit is 4,000 IU/day. (16) That makes “keep it adequate and safe” a far better goal than “keep it high”.

What this means for you

  • Correct a real deficiency — it is good for your bones, muscles and general health, and is reasonable around a melanoma diagnosis. (14,16)
  • Do not chase a high level as an anti-cancer tactic — the randomised evidence does not support it. (2,7)
  • Get vitamin D from diet and a supplement, not the sun. A practical guide is in nutrition and vitamin D for sun-avoidant patients →. (15)
  • Keep doing what works: sun protection and regular skin checks remain the proven foundation — see how to reduce your skin cancer risk →.

Book a skin check

Whatever your vitamin D level, the proven cornerstones of skin cancer care are sun protection and regular professional skin checks.

Frequently asked questions

  • Does taking vitamin D prevent skin cancer?
    On the best evidence, no — not in any clinically meaningful way. Large randomised trials of vitamin D supplements (including the Women's Health Initiative, VITAL and the Australian D-Health trial) did not reduce melanoma or keratinocyte skin cancers. Correcting a genuine deficiency is worthwhile for general health, but pushing vitamin D high with tablets is not a proven way to prevent skin cancer.
  • If I have had melanoma, will vitamin D improve my outcome?
    The strongest direct evidence says no. The randomised, placebo-controlled ViDMe trial raised vitamin D levels successfully but did not improve relapse-free or overall survival in melanoma patients. It is reasonable to correct a deficiency, but high-dose vitamin D is not an established treatment to reduce recurrence.
  • Then why does my doctor check my vitamin D after a melanoma diagnosis?
    Because low vitamin D at diagnosis is linked to thicker tumours and sometimes poorer survival, and because guidelines such as NICE recommend measuring it and correcting low levels. Checking and treating a deficiency is sensible — it is just not the same as proving that extra vitamin D changes the cancer itself.
  • I have heard higher vitamin D is linked to MORE skin cancer — is that true?
    Some studies do show that, but it is almost certainly because sunlight raises both your vitamin D level and your skin cancer risk at the same time. A high vitamin D reading often just marks higher sun exposure, so it is misleading rather than a sign that vitamin D causes cancer.
  • So what should I actually do about vitamin D?
    Aim for adequate, not high. Get vitamin D from diet and a supplement rather than deliberate sun exposure, correct a true deficiency under medical guidance, and keep up your sun protection and skin checks. There is no need to chase a high vitamin D target as an anti-cancer strategy.

References

  1. Tang JY, Fu T, Leblanc E, et al. Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin cancer: post hoc analyses of the Women's Health Initiative randomized controlled trial. J Clin Oncol. 2011;29(22):3078-3084.
  2. Manson JE, Cook NR, Lee IM, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease (VITAL). N Engl J Med. 2019;380(1):33-44.
  3. Chandler PD, Chen WY, Ajala ON, et al. Effect of vitamin D3 supplements on development of advanced cancer: a secondary analysis of the VITAL randomized clinical trial. JAMA Netw Open. 2020;3(11):e2025850.
  4. Ali S, Pham H, Waterhouse M, et al. The effect of vitamin D supplementation on risk of keratinocyte cancer: an exploratory analysis of the D-Health randomized controlled trial. Br J Dermatol. 2022;187(5):667-675.
  5. Virtanen JK, Nurmi T, Aro A, et al. Vitamin D supplementation and prevention of cardiovascular disease and cancer in the Finnish Vitamin D Trial (FIND): a randomized controlled trial. Am J Clin Nutr. 2022;115(5):1300-1310.
  6. Johansson H, Spadola G, Tosti G, et al. Vitamin D supplementation and disease-free survival in stage II melanoma: a randomized placebo-controlled trial. Nutrients. 2021;13(6):1931.
  7. De Smedt J, Van Kelst S, Janssen H, et al. High-dose vitamin D supplementation does not improve outcome in a cutaneous melanoma population: results of a randomized double-blind placebo-controlled study (ViDMe trial). Br J Dermatol. 2024;191(6):886-896.
  8. Galus Ł, Michalak M, Lorenz M, et al. Vitamin D supplementation increases objective response rate and prolongs progression-free time in patients with advanced melanoma undergoing anti-PD-1 therapy. Cancer. 2023;129(13):2047-2055.
  9. Lipplaa A, Fernandes R, Marshall A, et al. 25-hydroxyvitamin D serum levels in patients with high risk resected melanoma treated in an adjuvant bevacizumab trial (AVAST-M). Br J Cancer. 2018;119(7):793-800.
  10. Newton-Bishop JA, Beswick S, Randerson-Moor J, et al. Serum 25-hydroxyvitamin D3 levels are associated with Breslow thickness at presentation and survival from melanoma. J Clin Oncol. 2009;27(32):5439-5444.
  11. Mahamat-Saleh Y, Aune D, Schlesinger S. 25-Hydroxyvitamin D status, vitamin D intake, and skin cancer risk: a systematic review and dose-response meta-analysis of prospective studies. Sci Rep. 2020;10(1):13151.
  12. Tsai TY, Kuo CY, Huang YC. The association between serum vitamin D level and risk and prognosis of melanoma: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2020;34(8):1722-1729.
  13. Song Y, Lu H, Cheng Y. To identify the association between dietary vitamin D intake and serum levels and risk or prognostic factors for melanoma: systematic review and meta-analysis. BMJ Open. 2022;12(8):e052442.
  14. National Institute for Health and Care Excellence (NICE). Melanoma: assessment and management (NG14) — recommends measuring vitamin D at diagnosis.
  15. Cancer Council Australia. Position statements — sun exposure and vitamin D (obtain vitamin D from diet/supplements, not deliberate UV exposure).
  16. National Institutes of Health, Office of Dietary Supplements. Vitamin D — Fact Sheet for Health Professionals (sufficiency and upper-level reference ranges).

Portrait of Dr Christopher Irwin

By Dr Christopher Irwin, MBChB, FRACGP, MMed (Skin Cancer), FACAM, MSCCA

Last reviewed 2026-06-06 · Editorial policy